Promoting Excellence in Diabetes Care

Primary Care Best Practice Series

Practical, evidence-based conversations with leading experts, designed to help GPs and primary care teams deliver better diabetes care. Each session focuses on a real clinical gap and gives you clear, actionable guidance you can use in your next consult.

Episode 1: Metabolic Associated Fatty Liver Disease

Why liver screening belongs in routine diabetes care

“If you saw 11 patients with type 2 diabetes last week and you did not diagnose one with advanced fibrosis, you probably missed it.”
— Professor Fernando Bril, University of Alabama at Birmingham

Around two-thirds of people with type 2 diabetes or obesity have excess fat in the liver, and roughly 15 per cent already have clinically significant fibrosis. Yet it often goes undetected: there are usually no symptoms, and liver enzymes can appear normal well into the disease.

In this 25-minute conversation, Professor Bril joins Dr Gary Deed, GP and Chair of the RACGP Diabetes Specific Interests group, to discuss:

  • Who should be screened, and why type 2 diabetes is the highest-risk group
  • Using FIB-4 as the first-line test, interpreting the cut-offs, and avoiding age-related pitfalls
  • Next steps for an indeterminate result, including where elastography and the ELF test fit
  • Managing the whole metabolic picture, including the safe use of statins

If liver health hasn’t been a routine part of your diabetes reviews, this session will change what you order on your next round of bloods.